Keryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan’s 36th Annual Healthcare Conference on January 10, 2018...
December 22 2017 - 9:05AM
Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical
company focused on bringing innovative medicines to people with
kidney disease, today announced it will webcast its corporate
presentation at the 36th Annual J.P. Morgan Healthcare Conference
in San Francisco on Wednesday, January 10, 2018 at 11:30 a.m. PST
(2:30 p.m. EST). In addition, the company will webcast the question
& answer session immediately following its presentation at
12:00 p.m. PST (3:00 p.m. EST).
A live audio webcast of both the presentation
and breakout session will be accessible from Keryx’s website at
http://investors.keryx.com within the Investor Relations section
under “webcasts and presentations.” Archived versions of the
webcasts will be available for at least 15 days following the
conclusion of each session.
About Keryx Biopharmaceuticals,
Inc.Keryx Biopharmaceuticals, Inc., with headquarters in
Boston, Massachusetts, is focused on the development and
commercialization of innovative medicines that provide unique and
meaningful advantages to people with kidney disease. The Keryx team
consists of more than 200 committed people working with passion to
advance the care of people with this complex disease. This
dedication has resulted in two FDA-approved indications for Keryx’s
first medicine, Auryxia® (ferric citrate) tablets.
KERYX BIOPHARMACEUTICALS
CONTACT:Lora PikeSenior Director, Investor Relations &
Corporate CommunicationsT: 617-466-3511lora.pike@keryx.com
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Sep 2023 to Sep 2024